
The 10‐year intensive lifestyle intervention (ILI) of the Look AHEAD study left a legacy of relative deficits in cognitive function among participants who entered the clinical trial with obesity or a history of cardiovascular disease. The study hypothesized that altered levels of two weight‐sensitive proangiogenic cytokines, leptin and vascular endothelial growth factor (VEGF), accounted for this concerning finding. Alterations in two weight‐sensitive proangiogenic cytokines did not account for the long‐term adverse effects of ILI on cognitive function among adults with diabetes and either obesity or cardiovascular disease.
Like
Save
Share